Stay updated with breaking news from Pharmather Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PharmaDrug Inc (CSE:PHRX, OTCQB:LMLLF) has announced a $300,000 investment in its Sairiyo Therapeutics biotech subsidiary by PharmaTher Inc, a wholly-owned...
LONDON, Jan. 12, 2023 /PRNewswire/ -- The Psychedelic Drugs Market is anticipated to reach a valuation of USD 11.82 billion by 2029 from USD 4.87 billion in 2022, registering a CAGR of 13.49%
/PRNewswire/ -- The Psychedelic Drugs Market is anticipated to reach a valuation of USD 11.82 billion by 2029 from USD 4.87 billion in 2022, registering a CAGR...
Middle East and Africa Psychedelic Drugs Market research report intensely analyses the potential of the market with respect to the existing scenarios and future prospects by considering all industry aspects of this industry. Not to mention, to do well in this competitive marketplace, a market research report plays a...
Advancing clinical development of gout drug Bucillamine for infectious diseases, including COVID-19 Developing novel psilocybin and cannabidiol therapeutics for central nervous system and inflammatory disorders Revive Therapeutics Ltd (CSE:RVV) (OTCMKTS:RVVTF) is a life sciences company focused on the research and development of drugs for infectious diseases as well as central nervous system and inflammatory disorders. Its cannabinoid pharmaceutical portfolio focuses on rare inflammatory areas such as liver disease. The company has been granted orphan drug status designation by the US Food...